Trust Size
$103M
Current Price
$0.00
Peak Market Cap
$2.1B
Price Journey
What Happened
DermTech was a precision dermatology company that developed non-invasive skin genomics technology for melanoma detection, eliminating the need for surgical biopsies. The company went public via SPAC merger with Constellation Alpha Capital Corp in 2019. It filed for Chapter 11 bankruptcy in June 2024.
Constellation Alpha Capital Corp merged with DermTech in 2019. The company's non-invasive skin cancer test showed promise but struggled with reimbursement and commercialization. DermTech filed for Chapter 11 in June 2024, laid off 20% of staff, and sought a buyer for its technology. The company was renamed DTech Liquidating Inc as assets were sold off.
Timeline
2017-06-14
S-1 Registration Filed
2018-08-23
Merger Proxy Filed (DEFM14A)
2024-07-19
Last SEC Filing
2024-06-03
Filed for bankruptcy
SEC Filing Details
CIK Number
1651944
Total SEC Filings
496
State of Incorporation
DE
Last Filing Date
2024-07-19
Business Location
West Palm Beach, FL
Trust/Asset Size
$103M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for DermTech